A Trial Evaluating the Efficacy and Safety of the Sublingual Sufentanil Tablet 30 mcg for Post-Operative Pain After Abdominal Surgery

Completed · Phase 3 · Has a placebo group

Conditions studied: Post-Operative Pain

In brief

The purpose of this study is to compare the efficacy and safety of the sublingual Sufentanil Tablet (ST) 30 mcg to the sublingual Placebo Tablet (PT) for the short-term management of moderate-to-severe acute post-operative pain in patients after abdominal surgery.

Key facts

Study ID

NCT02356588

Run by

Talphera, Inc

People needed

161

Starts

2015-02-01

Expected to finish

2015-08-01

Last updated by the study team

2017-02-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Shoals Medical Trials, Inc — Sheffield, Alabama, United States
• Lotus Clinical Research — Pasadena, California, United States
• Victory Medical Center — Houston, Texas, United States
• Research Concepts, LLC — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.